Effects of Dapagliflozin Therapy on Renal Hemodynamics in Type 2 Diabetes Patients

被引：0
|
作者：
Qin, Yuejuan
Baskoy, Gozde
Triplitt, Curtis L.
Solis-Herrera, Carolina
Adams, John M., III
Defronzo, Ralph A.
Cersosimo, Eugenio
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-124-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
124-OR
引用
收藏
页数：2
相关论文
共 50 条
  • [21] THE EFFECTS OF CHRONIC DAPAGLIFLOZIN TREATMENT ON THE RENAL MICROVASCULATURE IN A RAT MODEL OF TYPE 2 DIABETES
    Ow, Connie
    Sukumaran, Vijayakumar
    Ngo, Jennifer
    Du, Cheng Kun
    Fujiwara, Akihiro
    Tsuchimochi, Hirotsugu
    Hosoda, Hiroshi
    Evans, Roger
    Pearson, James
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1301 - 1301
  • [22] Dapagliflozin in heart failure and type 2 diabetes: Efficacy, cardiac and renal effects, safety
    Yu, Pei-Ling
    Yu, You
    Li, Shuang
    Mu, Bai-Chen
    Nan, Ming-Hua
    Pang, Min
    [J]. WORLD JOURNAL OF DIABETES, 2024, 15 (07)
  • [23] THE EFFICACY AND RENAL SAFETY OF SWITCHING FROM DAPAGLIFLOZIN TO EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES
    Yang, Ai-Yu
    Chen, Hung-Chun
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1374 - 1374
  • [24] Effects of Dapagliflozin on Calcium-Phosphate Homeostasis in Patients with Type 2 Diabetes
    Kim, Kyoung Min
    Oh, Tae Jung
    Choi, Sung Hee
    Jang, Hak Chul
    Lim, Soo
    [J]. DIABETES, 2017, 66 : A347 - A348
  • [25] Effects of Dapagliflozin on Epicardial Fat Thickness in Patients with Type 2 Diabetes and Obesity
    Iacobellis, Gianluca
    Gra-Menendez, Silvia
    [J]. OBESITY, 2020, 28 (06) : 1068 - 1074
  • [26] SGLT2-independent metabolic Effects of Dapagliflozin in Patients with Type 2 Diabetes
    Kahl, S.
    [J]. DIABETOLOGE, 2016, 12 (07): : 498 - 499
  • [27] Dapagliflozin and Insulin Resistance in Patients with Type 2 Diabetes
    Katz, Arie
    Yeh, Helen
    [J]. DIABETES, 2015, 64 : A304 - A305
  • [28] Correction of anemia by dapagliflozin in patients with type 2 diabetes
    Stefansson, Bergur V.
    Heerspink, Hiddo J. L.
    Wheeler, David C.
    Sjostrom, C. David
    Greasley, Peter J.
    Sartipy, Peter
    Cain, Valerie
    Correa-Rotter, Ricardo
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2020, 34 (12)
  • [29] Dapagliflozin and cardiovascular outcomes in patients with Type 2 diabetes
    Al-Bazz, Dalai Y.
    Wilding, John P. H.
    [J]. FUTURE CARDIOLOGY, 2020, 16 (02) : 77 - 88
  • [30] Cardiovascular Outcomes with Dapagliflozin for Patients with Type 2 Diabetes
    Pavlicek, Vojtech
    [J]. DIABETOLOGE, 2019, 15 (03): : 262 - 264
12345